- Display 15 Products per page
Blood Testing Market in China (Typing, Immunoassay, NAT Testing)
Published: April 20, 2016 | Price: $2,000.00 – $4,000.00
Blood Testing Market in China (Typing, Immunoassay, NAT Testing) With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. Blood Testing Market in China offers the most current look at the blood testing IVD market in China, including tests for blood typing, immunoassay-based tests and NAT Tests. The report provides market analysis and data on the blood testing market environment in China, including: Blood...
Next-Generation-Sequencing for Non-Invasive Prenatal Testing (NGS-NIPT) in China
Published: June 29, 2016 | Price: $2,000.00 – $4,000.00
The Market for Next-Generation-Sequencing Neonatal Testing (NGS-NIPT) in China Next Generation NIPT Sequencing in China estimates the revenues for non-invasive prenatal testing in this emerging market, and generally analyzes the role of next generation sequencing (NGS) in the country. Estimates in this report include revenues for non-invasive prenatal testing using sequencing in China, projections to 2020, market share. Institutions performing NGS and key equipment manufacturers and service providers are discussed. This report was created as a cooperative project between Kalorama...
Next Generation Sequencing Markets (Systems, Consumables, Services, Competitive Analysis, Trends, Platforms)
Published: September 7, 2016 | Price: $2,000.00 – $4,000.00
This report, Next Generation Sequencing Markets (Systems, Consumables, Services, Competitive Analysis, Trends, Platforms) covers the market for NGS including a market estimate and a projection to 2020, regional growth for North America, Europe and Other regions, markets by disease category and instrument popularity from lab self reporting surveys. The report also covers investments in sequencing, trends and detail about manufacturers and service companies in NGS. A unique feature of this report is its focus on the interplay between...
Remote Patient Monitoring & Telemedicine Market (Sleep, Diabetes, Vital Signs/EKG and Other Monitors)
Published: September 14, 2016 | Price: $2,000.00 – $4,000.00
Advanced Remote Patient Monitoring Systems, 9th Edition (Telemedicine and Hospital Systems, Glucose, Blood Pressure, PT/INR, Cardiac Rhythm, EKG/ECG, Fetal Heart, EEG, Anesthesia, Pulse Oximeters, Sleep and Other Systems) Advanced Remote Patient Monitoring Systems, 9th Edition (Telemedicine and Hospital Systems, Glucose, Blood Pressure, PT/INR, Cardiac Rhythm, EKG/ECG, Fetal Heart, EEG, Anesthesia, Pulse Oximeters, Sleep and Other Systems) Advanced Remote Patient Monitoring Systems, in its 9th edition, specifically focuses on technologically advanced (including wireless and remote) patient monitors, monitors with patient data...
Contract Manufacturing of Medical Devices in China
Published: November 1, 2016 | Price: $2,000.00 – $4,000.00
Contract Manufacturing of Medical Devices in China This report looks at trends in the manufacturing of medical devices by contracted or outsourced companies for major device maufacturers. As part of its research the reprot includes market forecasts, lists of companies and other important business information. The market analysis in the report contains several segments based on processes withing outsroucing such as electronic parts, finished products or materials as well as clinical area breakouts.
Transplant Matching Molecular Diagnostics Market
Published: April 28, 2017 | Price: $2,000.00 – $4,000.00
Successful solid organ and hematopoietic stem cell (HSCT) or bone marrow transplants require histocompatibility between the recipient and donor. Molecular Technologies can be of assistance in this process. Autologous transplantation using hematopoietic cells from the same patient (donor and recipient) is increasingly common and eliminates the need to screen for histocompatibility. However, solid organ transplants and HSCT allografts from another donor requires histocompatibility confirmed by human leukocyte antigen (HLA) testing outside of genetically identical twins. This report, Transplant Matching Molecular...
The Top 25 IVD Companies: Revenue Performance, Products, Strategies, Market Activities
Published: October 5, 2017 | Price: $2,000.00 – $4,000.00
IVD Market Top 25 Companies: Revenue Performance, Products, Competitive Activity IVD Market Top 25 Companies presents advancements in in vitro diagnostics (IVD) by the Top 25 firms in the industry and provides an overview of the most recent trends and developments. Companies included are: Alere Inc. Arkray Beckman Coulter / Danaher Becton Dickinson Bio-Rad Laboratories bioMérieux Cepheid / Danaher Danaher Corp. (including Radiometer A/S) Grifols Hologic Illumina Instrumentation Laboratory / Werfen LabCorp, Laboratory Corporation of America Luminex Ortho Clinical Diagnostics...
The Market for Inherited Disease Molecular Diagnostic Testing
Published: October 13, 2017 | Price: $2,000.00 – $4,000.00
The Market for Inherited Disease Molecular Diagnostic Testing The detection of single nucleotide polymorphisms (SNPs) or gene variants from tissue, blood, urine and saliva samples can be used to diagnose inherited diseases and genetic disorders as well as determine the risk of disease manifestation or progression. Point mutations in genomic DNA occur when a single nucleotide (A,T,C, or G) sequence is altered. Many SNPs have no effect on cell function, but scientists believe others could predispose people to disease or...
Cancer Liquid Biopsy Market Assessment
Published: November 8, 2017 | Price: $2,000.00 – $4,000.00
Cancer Liquid Biopsy Market Assessment (Breast Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer) The term liquid biopsy encompasses various diagnostic methods that use liquid, non-tissue specimens to provide information that can aid in the diagnosis, treatment and monitoring of cancer. Currently, tissue biopsies, along with imaging techniques, are the standard methods used in the diagnosis of solid cancers, but despite their widespread use, they have many limitations that open the door for other diagnostic technologies in oncology clinical...
50 Key Biopharmaceutical and Biotechnology Companies
Published: December 12, 2017 | Price: $2,000.00 – $4,000.00
50 Key Biopharmaceutical and Biotechnology Companies Biopharmaceutical companies bring to market products that hold great promise for treating some of the most intractable medical conditions such as cancer and autoimmune disease. Biotech opportunities largely mirror those in the pharmaceutical industry. The key difference is that biotech firms are much more focused on research because they are still developing their initial products. 50 Key Biopharmaceutical and Biotechnology Companies is a comprehensive look at the top 50 companies that are shaping the...
Expected High Growth Market Segments in Molecular Diagnostic Testing
Published: December 14, 2017 | Price: $2,000.00 – $4,000.00
Expected High Growth Market Segments in Molecular Diagnostic Testing Tests for hepatitis, nucleic acid blood testing and respiratory testing are among the fast-growing segments of molecular testing in 2018, according to a new report from Kalorama Information. will exceed the average for revenue growth in molecular IVD, according to a new Kalorama Information report. Average molecular IVD products will see six percent growth, the areas identified will be higher, over the next five years. These are among the findings in...
Mergers and Acquisitions in the IVD Market
Published: June 28, 2019 | Price: $2,000.00 – $4,000.00
In vitro diagnostic (IVD) products continue to see positive sales growth in many categories. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. In this environment, companies are making strategic acquisitions that simultaneously add a revenue stream and product innovation. Kalorama Information looks at these market transactions in Mergers and Acquisitions in the IVD Market, recording more than 220 acquisitions in the diagnostics...
Blockchain Technologies in Healthcare
Published: November 22, 2019 | Price: $2,000.00 – $4,000.00
Blockchain is essentially a tool that has the potential to keep secure data in a distributed ledger with the capability to be shared across networks. The concept behind blockchain is that it has three components: a widely distributed network a shared ledger with validated access identities digital transactions Blockchain technology is emerging in many other industries but it has some unique challenges in healthcare. Blockchain Technologies in Healthcare discusses some of the major application areas for blockchain technology in healthcare:...
NASH Drug Pipeline and Market Overview
Published: January 6, 2020 | Price: $2,000.00 – $4,000.00
Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by inflammation in the liver and liver cell damage, which can lead to scarring of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment of this disease in terms of developer, type of drug, phase study, and market entrance estimate....
Outsourcing in Drug Discovery
Published: May 1, 2003 | Price: $2,062.00 – $4,152.00
The number and scope of drug discovery outsourcing agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part of drug discovery. Major pharmas and biotechs are aggressively pursuing a range of outsourcing agreements. On the supplier side, smaller vendors rely on outsourcing revenues to pay their bills and boost their credibility. Outsourcing in drug discovery is a popular topic for trade articles and seminars. These...